Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 62.20
-8.00 (-11.40%)
Jan 28, 2026, 5:00 PM CET
Urteste Revenue
Urteste had revenue of 712.00K PLN in the quarter ending September 30, 2025, with 962.69% growth. This brings the company's revenue in the last twelve months to 1.80M, up 42.86% year-over-year. In the year 2024, Urteste had annual revenue of 1.80M with 35.34% growth.
Revenue
1.80M
Revenue Growth
+42.86%
P/S Ratio
54.98
Revenue / Employee
50.00K
Employees
36
Market Cap
98.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.80M | 470.00K | 35.34% |
| Dec 31, 2023 | 1.33M | 1.33M | 44,233.33% |
| Dec 31, 2022 | 3.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 295.81M |
| Ryvu Therapeutics | 90.41M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Pharmena | 1.27M |
| Poltreg | 250.00K |